Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00674804 · ClinicalTrials.gov registry record
Communicating a Cancer Diagnosis-Current Methods and Their Effects
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 1,100
- Enrollment target
NCT00674804: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT00674804 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00674804 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 1,100 participants
- Enrollment target
Study Summary
This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will: * Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer. * Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed. * Identify who informs the patient of their diagnosis.. * Determine patient satisfaction with their diagnostic consult. * Identify indicators of satisfaction with the diagnostic consultation. Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study. Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2008-04-24 |
| Est. Completion | 2009-07-16 |
What the finished NCT00674804 record still lists
NCT00674804 is an observational study that tracks outcomes without assigning an intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00674804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00674804 about?
NCT00674804 is a clinical study titled "Communicating a Cancer Diagnosis-Current Methods and Their Effects". This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will: * Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer. * Determine if ...
What is the current status of trial NCT00674804?
This trial is currently completed. The enrollment target is 1,100 participants. The study started on 2008-04-24. Estimated completion is 2009-07-16.
Who is sponsoring clinical trial NCT00674804?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI